Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/29/20 → 4/29/23 |
Funding
- NCGS, Inc. (Prot #RAIN-701)
- Rain Therapeutics Inc. (Prot #RAIN-701)
Prot #RAIN-701: A Phase 2 Study to Evaluate the Clinical Activity of Tarloxotinib in Patients with Non-Small Cell Lung Cancer that Harbors Either an EGFR Exon 20 Insertion or a HER2-Activating Mutation and Other Advanced Solid Tumors with NRG1/ERBB Family
- Patel, Jyoti D (PD/PI)
Project: Research project